Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients

T.L. Laursen; K. Kazankov; T.D. Sandahl; H.J. Møller; L. Hagelskjær Kristensen; C. Holmboe; C. Sølund; H. Arildsen; A. Laursen; H. Grønbæk

doi:10.1016/S0168-8278(18)31339-4

Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients

T.L. Laursen, K. Kazankov, T.D. Sandahl, H.J. Møller, L. Hagelskjær Kristensen, C. Holmboe, C. Sølund, H. Arildsen, A. Laursen, H. Grønbæk

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	FRI-399
Tidsskrift	Journal of Hepatology
Vol/bind	68
Udgave nummer	Suppl. 1
Sider (fra-til)	S541
ISSN	0168-8278
DOI	https://doi.org/10.1016/S0168-8278(18)31339-4
Status	Udgivet - apr. 2018
Begivenhed	The International Liver Congress 2018 - Paris, Frankrig Varighed: 11 apr. 2018 → 15 apr. 2018

Konference

Konference	The International Liver Congress 2018
Land/Område	Frankrig
By	Paris
Periode	11/04/2018 → 15/04/2018

Adgang til dokumentet

10.1016/S0168-8278(18)31339-4

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Laursen, T. L., Kazankov, K., Sandahl, T. D., Møller, H. J., Hagelskjær Kristensen, L., Holmboe, C., Sølund, C., Arildsen, H., Laursen, A., & Grønbæk, H. (2018). Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients. Journal of Hepatology, 68(Suppl. 1), S541. Artikel FRI-399. https://doi.org/10.1016/S0168-8278(18)31339-4

@article{782121c133a8427c98414cf642358394,

title = "Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients",

author = "T.L. Laursen and K. Kazankov and T.D. Sandahl and H.J. M{\o}ller and {Hagelskj{\ae}r Kristensen}, L. and C. Holmboe and C. S{\o}lund and H. Arildsen and A. Laursen and H. Gr{\o}nb{\ae}k",

year = "2018",

month = apr,

doi = "10.1016/S0168-8278(18)31339-4",

language = "English",

volume = "68",

pages = "S541",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier",

number = "Suppl. 1",

note = "The International Liver Congress 2018 ; Conference date: 11-04-2018 Through 15-04-2018",

}

Laursen, TL, Kazankov, K, Sandahl, TD, Møller, HJ, Hagelskjær Kristensen, L, Holmboe, C, Sølund, C, Arildsen, H, Laursen, A & Grønbæk, H 2018, 'Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients', Journal of Hepatology, bind 68, nr. Suppl. 1, FRI-399, s. S541. https://doi.org/10.1016/S0168-8278(18)31339-4

Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients. / Laursen, T.L.; Kazankov, K.; Sandahl, T.D. et al.
I: Journal of Hepatology, Bind 68, Nr. Suppl. 1, FRI-399, 04.2018, s. S541.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients

AU - Laursen, T.L.

AU - Kazankov, K.

AU - Sandahl, T.D.

AU - Møller, H.J.

AU - Hagelskjær Kristensen, L.

AU - Holmboe, C.

AU - Sølund, C.

AU - Arildsen, H.

AU - Laursen, A.

AU - Grønbæk, H.

PY - 2018/4

Y1 - 2018/4

U2 - 10.1016/S0168-8278(18)31339-4

DO - 10.1016/S0168-8278(18)31339-4

M3 - Conference abstract in journal

SN - 0168-8278

VL - 68

SP - S541

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - Suppl. 1

M1 - FRI-399

T2 - The International Liver Congress 2018

Y2 - 11 April 2018 through 15 April 2018

ER -